These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15448440)

  • 21. Lactobacillus sepsis associated with probiotic therapy.
    Berger RE
    J Urol; 2005 Nov; 174(5):1843. PubMed ID: 16217308
    [No Abstract]   [Full Text] [Related]  

  • 22. Critical evaluation of probiotic activity of lactic acid bacteria and their effects.
    Heczko PB; Strus M; Kochan P
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():5-12. PubMed ID: 17242483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential risks of probiotics among HIV-infected persons: Bacteraemia due to Lactobacillus acidophilus and review of the literature.
    Haghighat L; Crum-Cianflone NF
    Int J STD AIDS; 2016 Nov; 27(13):1223-1230. PubMed ID: 26130690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic roles of Lactobacillus sp. in swine: insights from gut microbiota.
    Valeriano VD; Balolong MP; Kang DK
    J Appl Microbiol; 2017 Mar; 122(3):554-567. PubMed ID: 27914202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome.
    Vanderhoof JA; Young RJ; Murray N; Kaufman SS
    J Pediatr Gastroenterol Nutr; 1998 Aug; 27(2):155-60. PubMed ID: 9702645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential risk of probiotic usage.
    Barrett JF
    Expert Opin Drug Saf; 2006 Jan; 5(1):3-4. PubMed ID: 16370949
    [No Abstract]   [Full Text] [Related]  

  • 27. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
    Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
    Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactobacillus paracasei endocarditis in a consumer of probiotics.
    Franko B; Vaillant M; Recule C; Vautrin E; Brion JP; Pavese P
    Med Mal Infect; 2013 Apr; 43(4):171-3. PubMed ID: 23622954
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized controlled trial of probiotics after colonoscopy.
    D'Souza B; Slack T; Wong SW; Lam F; Muhlmann M; Koestenbauer J; Dark J; Newstead G
    ANZ J Surg; 2017 Sep; 87(9):E65-E69. PubMed ID: 26183594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of probiotics: comparison of two popular strains.
    Hammerman C; Bin-Nun A; Kaplan M
    BMJ; 2006 Nov; 333(7576):1006-8. PubMed ID: 17095783
    [No Abstract]   [Full Text] [Related]  

  • 32. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics in functional bowel disorders getting it right.
    Quigley EM
    J Clin Gastroenterol; 2011 Jul; 45(6):481-2. PubMed ID: 21617544
    [No Abstract]   [Full Text] [Related]  

  • 36.
    Gilliam CH; Brazelton de Cardenas J; Carias D; Maron Alfaro G; Hayden RT; Hakim H
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):484-487. PubMed ID: 35225182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.
    Feng JR; Wang F; Qiu X; McFarland LV; Chen PF; Zhou R; Liu J; Zhao Q; Li J
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1199-1208. PubMed ID: 28681177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics in the treatment of irritable bowel syndrome.
    Saggioro A
    J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteremic infection with Pediococcus: vancomycin-resistant opportunist.
    Barton LL; Rider ED; Coen RW
    Pediatrics; 2001 Apr; 107(4):775-6. PubMed ID: 11335758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitigating risk of bloodstream infection related to inpatient probiotic use.
    Polito NB; Avery LM
    Am J Health Syst Pharm; 2018 May; 75(10):595-596. PubMed ID: 29748296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.